STAT Plus: ASCO 2020 takeaways: AstraZeneca does a star turn, KRAS fizzles, and cell therapy shows progress
The annual meeting American Society of Clinical Oncology (ASCO) concluded on Sunday.
The closely-followed cancer research meeting is typically held over five days in Chicago. But for the first time, this year’s gathering was conducted entirely virtually due to the coronavirus pandemic. And while it ran for just three days — shorter than the normal five-day conference — there was no shortage of news, from AstraZeneca’s lung cancer results to progress on cell therapies.
Continue to STAT Plus to read the full story…
